Joshua M Staley

Joshua M Staley

University of Kansas Medical Center - Kansas City / United States
Others
AD Scientific Index ID: 5538552
person_outline Joshua M Staley's MOST POPULAR ARTICLES
1-) Randomized phase II trial of anthracycline-free and anthracycline-containing neoadjuvant carboplatin chemotherapy regimens in stage I–III triple-negative breast cancer (NeoSTOP)P Sharma, BF Kimler, A O\\\\\\\\\\\\\\\'Dea, L Nye, YY Wang, R Yoder, JM Staley, ...Clinical Cancer Research 27 (4), 975-982, 2021692021
2-) Clinical and biomarker results of neoadjuvant phase II study of pembrolizumab and carboplatin plus docetaxel in triple-negative breast cancer (TNBC)(NeoPACT).P Sharma, SR Stecklein, R Yoder, JM Staley, K Schwensen, A O\\\\\\\\\\\\\\\'Dea, ...Journal of Clinical Oncology 40 (16_suppl), 513-513, 2022482022
3-) Clinical and biomarker findings of neoadjuvant pembrolizumab and carboplatin plus docetaxel in triple-negative breast cancer: NeoPACT phase 2 clinical trialP Sharma, SR Stecklein, R Yoder, JM Staley, K Schwensen, A O’Dea, ...JAMA oncology 10 (2), 227-235, 2024302024
4-) Impact of low versus negative estrogen/progesterone receptor status on clinico-pathologic characteristics and survival outcomes in HER2-negative breast cancerR Yoder, BF Kimler, JM Staley, K Schwensen, YY Wang, K Finke, A O’Dea, ...npj Breast Cancer 8 (1), 1-7, 2022322022
5-) Making Sense of Pharmacovigilance and Drug Adverse Event Reporting: Comparative Similarity Association Analysis Using AI Machine Learning Algorithms in Dogs and CatsX Xu, R Mazloom, A Goligerdian, J Staley, M Amini, G Wyckoff, J Riviere, ...Topics in Companion Animal Medicine, 100366, 2019232019